These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis. Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation. Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770 [TBL] [Abstract][Full Text] [Related]
4. Impact of body mass index in liver transplantation for nonalcoholic fatty liver disease and alcoholic liver disease. O'Neill S; Napetti S; Cornateanu S; Sutherland AI; Wigmore S; Oniscu GC; Adair A HPB (Oxford); 2017 Dec; 19(12):1074-1081. PubMed ID: 28888774 [TBL] [Abstract][Full Text] [Related]
5. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607 [TBL] [Abstract][Full Text] [Related]
6. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times. Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778 [TBL] [Abstract][Full Text] [Related]
8. Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis. Bhati C; Idowu MO; Sanyal AJ; Rivera M; Driscoll C; Stravitz RT; Kohli DR; Matherly S; Puri P; Gilles H; Cotterell A; Levy M; Sterling RK; Luketic VA; Lee H; Sharma A; Siddiqui MS Transplantation; 2017 Aug; 101(8):1867-1874. PubMed ID: 28296807 [TBL] [Abstract][Full Text] [Related]
9. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874 [TBL] [Abstract][Full Text] [Related]
10. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. John BV; Aiken T; Garber A; Thomas D; Lopez R; Patil D; Konjeti VR; Fung JJ; McCollough AJ; Askar M Exp Clin Transplant; 2018 Aug; 16(4):439-445. PubMed ID: 29863454 [TBL] [Abstract][Full Text] [Related]
11. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption. Vilar-Gomez E; Sookoian S; Pirola CJ; Liang T; Gawrieh S; Cummings O; Liu W; Chalasani NP Gastroenterology; 2020 Sep; 159(3):929-943. PubMed ID: 32454036 [TBL] [Abstract][Full Text] [Related]
12. Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation. Nagpal SJ; Kabbany MN; Mohamad B; Lopez R; Zein NN; Alkhouri N Dig Dis Sci; 2016 Jul; 61(7):2102-7. PubMed ID: 26993824 [TBL] [Abstract][Full Text] [Related]